phase 2_completion
saveSun Pharmaceutical Industries Ltd — Absorica (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Neuroblastoma
Data sources
globaldata
Found something off?
drug timeline · 8
- approvalISOTRETINOIN — FDA approvalFeb 9, 2026 · 240d ago
- approvalZENATANE (ISOTRETINOIN) — FDA approvalFeb 9, 2026 · 240d ago
- approvalISOTRETINOIN — FDA approvalJan 29, 2024 · 982d ago
- approvalZENATANE (ISOTRETINOIN) — FDA approvalMar 24, 2023 · 1293d ago
- approvalZENATANE (ISOTRETINOIN) — FDA approvalOct 6, 2022 · 1462d ago
- approvalZENATANE (ISOTRETINOIN) — FDA approvalAug 23, 2022 · 1506d ago
- approvalZENATANE (ISOTRETINOIN) — FDA approvalAug 4, 2022 · 1525d ago
- approvalZENATANE (ISOTRETINOIN) — FDA approvalNov 9, 2021 · 1793d ago
same company · ±60 days · 5
- phase 3 initiationruxolitinib: Sun Pharmaceutical Industries Ltd — ruxolitinib (Phase III Trial Initiation)Apr 27, 2026
- drug shortageLisdexamfetamine Dimesylate Capsule shortage — Sun Pharmaceutical Industries, Inc.Apr 17, 2026
- drug shortageMethylphenidate Hydrochloride Tablet, Extended Release shortage — Sun Pharmaceutical Industries, Inc.Apr 17, 2026
- drug shortageTechnetium TC-99M Pyrophosphate Kit Injection shortage — Sun Pharmaceutical Industries, Inc.Apr 17, 2026
- drug shortageLisdexamfetamine Dimesylate Tablet, Chewable shortage — Sun Pharmaceutical Industries, Inc.Apr 17, 2026
🐶 often sniffed alongside
top 8- tagApproval374 co-mentions · 187 sources
- drugZENATANE339 co-mentions · 190 sources
- drugAbsorica220 co-mentions · 190 sources
- tagSmall Molecule187 co-mentions · 187 sources
- companyTeva Pharmaceuticals USA Inc4 co-mentions · 2 sources
- tagRecall3 co-mentions · 3 sources
- companyMylan Pharmaceuticals Inc2 co-mentions · 1 sources
- companyAurobindo Pharma Ltd2 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that